Distribution of APOE genotypes in 91 patients with Guillain-Barré syndrome compared with a Scottish population9 and a mixed UK/USA population10
| Genotype | ||||||
|---|---|---|---|---|---|---|
| 2/2 | 2/3 | 3/3 | 2/4 | 3/4 | 4/4 | |
| GBS, Guillain-Barré syndrome. | ||||||
| All GBS patients (n=91) (frequency) | 0 (0.000) | 5 (0.055) | 68 (0.744) | 0 (0.000) | 17(0.187) | 1 (0.011) |
| Scottish population (n=406) (frequency) | 4 (0.010) | 45 (0.110) | 222 (0.550) | 13 (0.030) | 110 (0.270) | 12 (0.030) |
| Mixed population (n=169) (frequency) | 2 (0.012) | 23 (0.136) | 107(0.633) | 3 (0.018) | 31 (0.183) | 3 (0.018) |
| Good outcome GBS patients (n=81) (frequency) | 0 (0.000) | 5 (0.062) | 60(0.741) | 0 (0.000) | 15 (0.185) | 1 (0.012) |
| Poor outcome GBS patients (n=10) (frequency) | 0 (0.000) | 0 (0.000) | 8 (0.800) | 0 (0.000) | 2 (0.200) | 0 (0.000) |
| Worst disability of grade 3, 4, or 5 (n=78) (frequency) | 0 (0.000) | 5 (0.064) | 56 (0.718) | 0 (0.000) | 16 (0.205) | 1 (0.013) |
| Improved by ≥3 disability grades from grade 3, 4, or 5 (n=51) (frequency) | 0 (0.000) | 5 (0.098) | 34 (0.667) | 0 (0.000) | 11 (0.216) | 1 (0.020) |